Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.
Emerging technologies, the latest clinical applications, best practices, and more are waiting for you. The 2022 Virtual SNMMI Mid-Winter and ACNM Annual Meeting will feature three educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on cardiovascular nuclear medicine.
Unfortunately, the ongoing COVID-19 global pandemic and surging Omicron variant have forced us to cancel our planned in-person event in Orlando. We are excited to announce that a Virtual 2022 SNMMI Mid-Winter and ACNM Annual Meeting will now take place Friday, February 25 through Sunday, February 27, 2022. Read the full announcement.
Make your plans to attend the SNMMI Therapeutics Conference, in-person, March 10-12, 2022 at the Hyatt Regency New Orleans. This two-and-a-half-day event will explore the latest innovations and clinical applications in radiopharmaceutical therapy.
Early-bird registration deadline: Thursday, January 20, 2022
Make 2022 the year you take the next important step in your career path. Submit your abstract by Tuesday, January 11, 2022, for the opportunity to present and publish innovative scientific investigations to a global audience of medical imaging professionals at the SNMMI 2022 Annual Meeting, June 11-14, 2022 in Vancouver, BC, Canada.
Due to the surging Omicron variant, we have made the decision to provide you with more time to submit your abstract for the SNMMI 2022 Annual Meeting.
You now have until Tuesday, January 25, 2022, to submit your abstract for the opportunity to present your research in Vancouver or virtually.
The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.
For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.
For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.
Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!
In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.
SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.
The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.
SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.
The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.
SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors.
Research published in the January issue of JNM has confirmed the accuracy of the European Association of Urology risk classification system that groups prostate cancer patients based on their risk of recurrence.
On January 11, CMS announced that it proposes to cover FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under CED in CMS-approved randomized controlled trials. SNMMI reacts.
When assessed together in an AI model, coronary F-18 NaF uptake on PET and quantitative coronary plaque characteristics on CT angiography were found to provide risk prediction superior to that of clinical data alone.
SNMMI and peer medical groups have issued AUC for PSMA PET imaging. Published in the January issue of JNM, the criteria are the product of an international multidisciplinary panel of expert healthcare providers.
SNMMI—the leader in radiopharmaceutical therapy education and resources—is excited to announce the launch of a new therapy-focused web portal for members, researchers, the medical community, and patients.
This portal has been created as a repository for all things therapy, providing you with direct access to SNMMI's comprehensive content in one location. We encourage you to bookmark this page for direct access to therapy-related content, including:
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.